Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | 0.58% | 62.99 | 1.0% | $429.08m | |
| AMGN | Amgen, Inc. | 0.00% | 237.60 | 1.3% | $415.39m | |
| BIIB | Biogen, Inc. | 0.46% | 288.50 | 1.4% | $364.64m | |
| ILMN | Illumina, Inc. | -0.10% | 328.00 | 3.5% | $323.24m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.78% | 233.99 | 1.9% | $273.36m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.51% | 365.55 | 2.6% | $218.36m | |
| EXAS | EXACT Sciences Corp. | 0.82% | 86.60 | 24.0% | $198.72m | |
| ITCI | Intra-Cellular Therapies, Inc. | 0.28% | 25.50 | 9.0% | $173.94m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.23% | 113.01 | 2.0% | $173.06m | |
| INCY | Incyte Corp. | -2.30% | 78.65 | 2.5% | $135.12m | |
| SRPT | Sarepta Therapeutics, Inc. | -1.55% | 121.08 | 14.6% | $130.98m | |
| A | Agilent Technologies, Inc. | -0.01% | 89.61 | 1.6% | $120.05m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -0.82% | 87.55 | 4.3% | $106.16m | |
| BLUE | bluebird bio, Inc. | -2.26% | 95.82 | 14.2% | $95.27m | |
| SGEN | Seattle Genetics, Inc. | -0.30% | 108.67 | 6.1% | $90.33m |
Company Profile
Nektar Therapeutics is a biopharmaceutical company, which engages in applying technology platforms to develop novel drug candidates. The company focuses on the therapies for cancer, autoimmune disease, and chronic pain. It operates through the United States and Europe geographical segments. The company was founded in 1990 and is headquartered in San Francisco, CA.